Anti-inflammatory activity of theophylline on carrageenan-induced paw edema in male wistar rats

K Srinivasa ., BVS Chandrasekhar, J Srinivasa

Abstract


Background: Evaluate the anti-inflammatory property of theophylline on rat hind paw edema using carrageenan-induced acute inflammatory model.

Methods: Wistar male rats (150-200 gm) were divided into 7 groups- 3 standard groups, 3 test groups and 1 control group. Each group consists of six rats. A control group was treated with 0.2ml of normal saline, 3 standard groups were treated with different doses of Diclofenac (Standard drug): 5 mg/kg, 10 mg/kg, 15 mg/kg body weight, respectively and 3 test groups  were  treated with different doses of Theophylline (Test drug):  5 mg/kg , 10 mg/kg  and 15 mg/kg, respectively. The anti-inflammatory property was assessed by plethysmograph.

Results: Theophylline demonstrated a significant anti-inflammatory property at different dose levels when compared to controls (p > 0.05). However this anti-inflammatory activity was less as compared to standard drug.

Conclusions: Theophylline exhibited a dose dependent anti-inflammatory activity in a carrageenan model of inflammation.


Keywords


Theophylline, Carrageenan, Anti-inflammatory activity

Full Text:

PDF

References


Mahat MA, Patil BM. Evaluation of anti-inflammatory activity of methanol extract of Phyllanthus amarus in experimental animal models. Indian J Pharma Sci 2007;69:33-6.

Sosa S, Balick MJ, Arvigo R, Esposito RG, Pizza C, Altinier G, Tubaro A. Screening of the topical anti-inflammatory activity of some Central American plants. J Ethnopharmacol 2002;81:211-5.

Amdekar S, Roy P, Singh V, Kumar A, Singh R, Sharma P. Anti-Inflammatory Activity of Lactobacillus on Carrageenan-Induced Paw Edema in Male Wistar Rats. Int J Inflam 2012;2012:752015.

Barnes PJ. Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med 2003;167:813-8.

Milgrom H, Bender B. Current issues in the use of theophylline. Am Rev Respir Dis 1993;147(6 Pt 2):S33-9.

Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994:343:1006-8.

Torphy TJ, Undem BJ. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 1991:46:512-23.

Spatafora M, Chiappara G, Merendino AM, D'amico D, Bellia V, Bonsignore G. Theophylline suppresses the release of tumour necrosis factor-a by blood monocytes and alveolar macrophages. Eur Respir J 1994;7:223-8.

Kulkarni SK. Handbook of Experimental Pharmacology. 3rd ed. Delhi: Vallabh Prakashan; 2007:128-31.

Wills AL. Release of histamine, kinin and prostaglandins during carrageenin induced inflammation of the rats. In Prostaglandins, Peptides and Amines. Montagazza P, Horton EW, Eds. Academic Press, London, UK; 1969:31-48.

Bhukya B, Anreddy RNR, William CM, Gottumukkala KM. Analgesic and anti-inflammatory activities of leaf extract of Kydia calycina Roxb. Bangladesh J Pharmacol 2009;4:101-4.

Brooks PM, Day RO. Non-steroidal anti-inflammatory drugs difference and similarities. N Engl J Med 1991;324:1716-25.

Nielson CP, Crowley JJ, Cusack BJ, Vestal RE. Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activation. J Allergy Clin Immunol 1986;78:660 -7.

Nielson CP, Crowley JJ, Morgan ME, Vestal RE. Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic-3’,5’-adenosine monophosphate. Am Rev Respir Dis 1988;137:25-30.

O’Neill SJ, Sitar DS, Klass DJ, et al. The pulmonary disposition of theophylline and its influence on human alveolar macrophage bactericidal function. Am Rev Respir Dis 1986;134:1225-8.

Nelson S, Summer WR, Jakab GJ. Aminophylline-induced suppression of pulmonary antibacterial defenses. Am Rev Respir Dis 1985;131:923-7.